![Omar Khalil](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Omar Khalil
Directeur/Membre du Conseil chez
Solu Therapeutics
Profil
Omar Khalil is currently Managing Director at SHVMS, LLC since 2024.
Mr. Khalil is Director at Geneos Therapeutics, Inc. since 2023.
Mr. Khalil is Director at Kestrel Therapeutics, Inc. since 2022.
Mr. Khalil is Director at Solu Therapeutics, Inc. since 2023.
Mr. Khalil is Board Member at MycRX since 2021.
Former roles include Vice President & US Hospital Products at Baxter International, Inc. from 2015 to 2017, Vice President & General Manager at Kaleo, Inc. from 2017 to 2020, and Principal at McKinsey & Co., Inc. Education includes undergraduate and graduate degrees from the University of Michigan.
Postes actifs de Omar Khalil
| Sociétés | Poste | Début |
|---|---|---|
SHVMS, LLC
 SHVMS, LLC Investment ManagersFinance Sante Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical technologies, biotechnology, healthcare services and healthcare IT. It provides financing for seed and early-stage capital requirements. | Private Equity Investor | 01/01/2020 |
Kestrel Therapeutics, Inc.
 Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology development company | Directeur/Membre du Conseil | 01/01/2022 |
Solu Therapeutics
 Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Directeur/Membre du Conseil | 01/01/2023 |
MycRx
 MycRx Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops small molecule inhibitors of the Myc oncoprotein | Directeur/Membre du Conseil | 01/01/2021 |
Geneos Therapeutics, Inc.
 Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies | Directeur/Membre du Conseil | 01/01/2023 |
Anciens postes connus de Omar Khalil
| Sociétés | Poste | Fin |
|---|---|---|
Kaleo, Inc.
 Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug or device combination products | Private Equity Investor | 01/01/2020 |
| BAXTER INTERNATIONAL INC. | Corporate Officer/Principal | 01/01/2017 |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Formation de Omar Khalil
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
37
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Baxter International, Inc.
 Baxter International, Inc. Medical SpecialtiesHealth Technology Produces and supplies medical products, healthcare systems, therapies and pharmaceuticals & provide kidney care services | Health Technology |
Kaleo, Inc.
Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Develops drug or device combination products | Health Technology |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
University of Michigan
 University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SHVMS, LLC
SHVMS, LLC Investment ManagersFinance Sante Ventures invests in companies located in the United States. The firm targets companies operating in the fields of medical technologies, biotechnology, healthcare services and healthcare IT. It provides financing for seed and early-stage capital requirements. | Finance |
Geneos Therapeutics, Inc.
Geneos Therapeutics, Inc. BiotechnologyHealth Technology Develops and commercializes neo-antigen based personalized cancer therapies | Health Technology |
Kestrel Therapeutics, Inc.
Kestrel Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology development company | Commercial Services |
MycRx
MycRx Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company that develops small molecule inhibitors of the Myc oncoprotein | Commercial Services |
Solu Therapeutics
Solu Therapeutics BiotechnologyHealth Technology Operates as a biotechnology that develops therapeutics to eliminate disease-driving cells in cancer, immunology and autoimmunity | Health Technology |
Choisissez Zonebourse 
